[Erythema multiforme in children versus Stevens-Johnson syndrome]

Area of Science:

• Pediatrics
• Dermatology
• Allergology

Background:

• Erythema multiforme (EM) is a rare condition in children, with varying severity.
• EM minor typically presents with a benign course.
• Stevens-Johnson Syndrome (SJS), a severe form of EM involving mucous membranes, carries a grave prognosis.

Purpose of the Study:

• To analyze the clinical characteristics and potential triggers of erythema multiforme in pediatric patients.
• To differentiate between erythema multiforme minor and Stevens-Johnson Syndrome in children.

Main Methods:

• Retrospective analysis of 30 pediatric patients treated for erythema multiforme between 1984 and 1998.
• Classification of patients into erythema multiforme minor (25 cases) and Stevens-Johnson Syndrome (5 cases).
• Review of patient histories for preceding infections and drug therapies.

Main Results:

• 25 children had erythema multiforme minor, and 5 had Stevens-Johnson Syndrome.
• Preceding infections (mostly viral) were noted in 27 children.
• Antibiotic treatment preceded symptom onset in 13 children.
• Drug therapies and infections are implicated as potential triggers for EM and SJS in susceptible children.

Conclusions:

• Erythema multiforme is uncommon in children, with EM minor being the most frequent and benign form.
• Stevens-Johnson Syndrome is a severe manifestation requiring aggressive management.
• Infections and medications are key factors in the etiopathogenesis of EM.
• Symptomatic treatment is standard for EM; early glucocorticoid administration is advised for SJS, alongside antibiotics for bacterial infections.